Project Details
| Short title | Translational study for dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC |
|---|---|
| Status | Finished |
| Effective start/end date | 1/05/23 → 30/04/25 |
Funding
- IOX Therapeutics
Translational study for dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC
- De Santo, Carmela (Principal Investigator)